EMN EASTMAN CHEMICAL CO Insider Trading

EVP Brian Travis Smith bought 1,750 shares of EMN at $68.34; 10 insiders also bought in past 14 days amid 38.2% decline from 52-week high.

Brian Travis Smith, EVP of AFP, Manufacturing, WWEC & HSE at Eastman Chemical, purchased 1,750 shares at $68.34, increasing his holdings to 16,732 shares (+11.7% vs pre-transaction holdings). The transaction occurs in a material cluster pattern: 10 other insiders also executed purchases within the past 14 days. This coordinated buying activity coincides with significant price pressure—the stock trades at $70.34, down 38.2% from its 52-week high of $113.77 and down 10.2% over the past 90 days. The company maintains stable fundamentals with Revenue of $2,287,000,000.00 in the latest quarter, Net income of $140,000,000.00, and a P/E of 9.70, suggesting valuation may not reflect operational deterioration. The cluster buy pattern by multiple executives during sustained price weakness warrants investor attention to whether insiders perceive value misalignment or have forward-looking information about business trajectory.

CEO Costa Mark J bought 7,400 shares of EMN at $67.89 on 2025-08-27 (total $502.4K); stock down 40.1% from 52-week high, cluster of 10 other insiders bought within 14 days.

CEO Costa Mark J purchased 7,400 shares at $67.89, increasing his holdings by 1.7% to 453.986 shares, amid a broader cluster pattern where 10 other insiders also bought within the past 14 days. The purchase occurs with EMN trading at $68.18 current price, down 40.1% from its 52-week high of $113.77 and down 10.0% over the past 30 days and 13.0% over 90 days. Historically, Costa's prior trades at EMN show a pattern of 4 of 5 sells that were well-timed at the 90-day mark, with negative 90-day returns on those sells, suggesting sound sell discipline; however, his cross-ticker buy track record shows 0.00% 90-day win rate (both prior buys were underwater by 90 days), while his cross-ticker sells demonstrated 71.43% well-timed rate. The coordinated buying activity among multiple insiders at a depressed price level offers a different signal than this individual's historical buy performance, warranting assessment of whether the broader team sees current valuation as attractive relative to fundamentals (P/E 9.40, $2.3B revenue, $140.0M net income).

Director Eric L Butler buys 3,000 EMN shares at $68.65; 10 other insiders also bought within 14 days, cluster pattern amid -40.1% decline from 52-week high.

Director Eric L Butler purchased 3,000 shares of Eastman Chemical at $68.65, increasing his holdings by 47.4% from 6,330 to 9,330 shares. This transaction occurs as part of a cluster pattern: 10 other insiders also bought within the past 14 days, suggesting coordinated or opportunistic accumulation. The stock has declined -40.1% from its 52-week high of $113.77 and is down -10.0% over the past 30 days and -13.0% over 90 days, trading at $68.18 currently. The company shows modest fundamentals with annual revenue growth of +1.9%, a P/E of 9.40, and $140.0M in net income on $2.3B quarterly revenue, suggesting the purchase may reflect insider assessment of valuation after recent price deterioration.

SVP McAlindon buys 2,000 EMN shares at $68.43; stock down 40.1% from 52-week high; 10-insider cluster buy in 14 days

McAlindon, an SVP in charge of Regions and Chief Supply Chain Operations, purchased 2,000 shares at $68.43 on 2025-08-27, increasing her holdings by 18.6% to 12.7K shares. The transaction occurs within a notable cluster: 10 other insiders also bought within the past 14 days, suggesting coordinated confidence at a depressed price level. The stock is currently trading at $68.18, down 40.1% from its 52-week high of $113.77 and down 10.0% over the past 30 days, though the company maintains solid fundamentals with $2.3B quarterly revenue, $140.0M net income, and a P/E of 9.40. The synchronized buying pattern by multiple executives during a sharp drawdown warrants attention as an indicator of potential value recognition by management.

EVP & CCO Brad Lich buys 3,280 shares of EMN at $68.49; stock down 40.1% from 52-week high amid 10-insider cluster buy.

Brad Lich, EVP & Chief Compliance Officer, purchased 3,280 shares at $68.49 on 2025-08-27, increasing his holdings from 80,207 to 83,487 shares. The purchase occurred as EMN trades -40.1% from its 52-week high and down 10.0% over 30 days, following declines of -12.2% and -12.6% in 30-day windows after Lich's two most recent sales at this same ticker in late November and early December 2024. Notably, 10 other insiders also bought within the past 14 days, establishing a cluster buy pattern. The company's fundamentals remain solid with $2.3B quarterly revenue, a P/E of 9.40, and 1.9% annual revenue growth, suggesting the purchase occurs in a compressed valuation context rather than a growth inflection.

Director Mink Kim Ann bought 1,450 shares of EMN at $69.38; cluster of 10 other insiders buying within 14 days; stock down 40.1% from 52-week high.

Mink Kim Ann (Director) purchased 1,450 shares at $69.38 on 2025-08-27, increasing her holdings by 104.3% to 2,840 shares post-transaction. This transaction occurred as part of a cluster pattern: 10 other insiders also bought within the past 14 days. Notably, the stock is trading at $68.18 (current price), down 40.1% from its 52-week high of $113.77 and down 10.0% over the past 30 days and 13.0% over 90 days. The company trades at a P/E of 9.40 with a market cap of $7,829,273,850.16, while recent quarterly fundamentals show $2,287,000,000.00 in revenue and $140,000,000.00 in net income.

EMN CFO William McLain buys 3.7K shares at $68.73 as 11 insiders accumulate in 14 days

CFO McLain William Thomas Jr. purchased 3,670 shares of Eastman Chemical at $68.73, raising his holdings from 49.9K to 53.5K shares (+7.4%). The transaction occurs within a 14-day cluster in which 10 other insiders also bought, a rare synchronized accumulation pattern that reflects coordinated purchasing activity at the executive level. The stock trades at $68.18, down -40.1% from its 52-week high of $113.77 and down -10.0% over the trailing 30 days, creating a significant markdown from recent peaks. With a P/E of 9.40, market cap of $7.8B, and recent quarterly revenue of $2.3B, the company exhibits modest fundamentals (annual revenue growth of +1.9%, net income of $140.0M), making the synchronized insider accumulation at depressed levels a material signal of executive positioning amid suppressed valuation.

Director O'Brien buys 1,450 EMN shares at $68.81; 10 other insiders also purchased within 14 days amid -40.1% drop from 52-week high.

Director James J. O'Brien purchased 1,450 shares at $68.81 on 2025-08-27, increasing his holdings by 27.0% to 6,828 shares. This transaction occurs within a broader cluster pattern: 10 other insiders also bought EMN within the past 14 days. The stock is trading at $68.18 (current), down 40.1% from its 52-week high of $113.77 and down 10.0% over the past 30 days, yet the company maintains solid fundamentals with $2.3B quarterly revenue, $140.0M net income, and a P/E of 9.40. The convergence of multiple insider purchases during a sharp drawdown—particularly after a 90-day decline of 13.0%—points to coordinated insider accumulation at depressed levels, warranting examination of whether recent price action has created a disconnect from underlying business performance or whether insiders perceive material value.

Director Begemann buys 1,500 shares of EMN at $68.28; cluster of 10 other insiders bought in past 14 days amid -40.1% from 52-week high.

Director Brett D. Begemann purchased 1,500 shares of Eastman Chemical at $68.28, increasing his holdings by 18.7% from 8,020 to 9,520 shares. This transaction occurs within a broad insider buying cluster: 10 other insiders bought within the past 14 days. The stock is currently trading at $68.18, down -40.1% from its 52-week high of $113.77 and down -10.0% over the past 30 days, having declined -13.0% over 90 days. While the company maintains a P/E of 9.40 and generated $2.3B in quarterly revenue with $140.0M net income, the confluence of multiple insider purchases during a period of significant price depreciation warrants examination of whether these transactions reflect confidence at lower valuations or reflect broader strategic positioning in response to company performance.

Director Audia Damon J acquired 1,465 shares of EMN at $68.58 on 2025-08-27 amid 10-insider cluster buy pattern.

Director Audia Damon J purchased 1,465 shares for $100,477.03, expanding holdings by +1109.8% from 132 shares to 1,597 shares post-transaction. The buy occurs within a cluster window in which 10 other insiders also bought within the past 14 days, suggesting coordinated accumulation activity across the executive base. The stock has declined -40.1% from its 52-week high of $113.77 and -13.0% over the trailing 90 days, pricing the buy well below recent peaks. With a P/E of 9.40 and market cap of $7,829,273,850.16 against annualized revenue trends of +1.9%, the company's valuation context and the breadth of insider buying merit investor attention to understand what conviction or catalysts may be driving synchronized purchases across multiple insider accounts.